| P2093 | author name string | Bressolle F | |
| | Joubert P | |
| | Saissi G | |
| | Gouby A | |
| | Martinez JM | |
| | Guillaud R | |
| | Gomeni R | |
| P2860 | cites work | Prediction of creatinine clearance from serum creatinine | Q29615603 |
| | Comparison of methods for estimating gentamicin clearance and retrospective analysis of changes in clearance with emphasis on patients with normal renal function | Q34620939 |
| | Application of a Bayesian method to monitor and adjust vancomycin dosage regimens | Q35261758 |
| | Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations | Q35674282 |
| | Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic data | Q36662092 |
| | Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapy | Q36753828 |
| | Pharmacokinetic evaluation of single daily dose amikacin | Q37193898 |
| | Practical computer-assisted dosing for aminoglycoside antibiotics | Q39874941 |
| | Parenteral aminoglycoside therapy. Selection, administration and monitoring | Q40392377 |
| | Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package | Q40572839 |
| | A prospective randomised trial comparing individualised pharmacokinetic dosage prediction for aminoglycosides with prediction based on estimated creatinine clearance in critically ill patients | Q43446209 |
| | Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 |
| | The pharmacokinetics of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens | Q46960940 |
| | A Two-Step Iterative Algorithm For Estimation In Nonlinear Mixed-Effect Models With An Evaluation In Population Pharmacokinetics | Q52337597 |
| | Comparison of methods of estimating creatinine clearance in children. | Q52436520 |
| | A controlled trial of the cost benefit of computerized bayesian aminoglycoside administration. | Q52447951 |
| | Application of Bayesian estimation for the prediction of an appropriate dosage regimen of amikacin. | Q52522833 |
| | Evaluation of a Bayesian method of amikacin dosing in intensive care unit patients with normal or impaired renal function. | Q52594977 |
| | A Bayesian feedback method of aminoglycoside dosing. | Q52675073 |
| | Some suggestions for measuring predictive performance | Q52875851 |
| | Plasma creatinine, and clearance and urinary excretion of creatinine in children | Q67315260 |
| | Single daily dose amikacin in paediatric patients with severe Gram-negative infections | Q67920887 |
| | Prospective comparison of traditional and pharmacokinetic aminoglycoside dosing methods | Q68465414 |
| | Postantibiotic effect of aminoglycosides on gram-negative bacteria evaluated by a new method | Q70405372 |
| | Detection of nosocomial lung infection in ventilated patients. Use of a protected specimen brush and quantitative culture techniques in 147 patients | Q70414345 |
| | Population pharmacokinetic modeling: the importance of informative graphics | Q71485685 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacokinetics | Q323936 |
| | amikacin | Q408529 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1682-1689 | |
| P577 | publication date | 1996-07-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Population pharmacokinetics of amikacin in critically ill patients | |
| P478 | volume | 40 | |